Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for BAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 8.857B
March 31, 2026 9.687B
December 31, 2025 9.698B
September 30, 2025 9.708B
June 30, 2025 9.719B
March 31, 2025 10.30B
December 31, 2024 11.24B
September 30, 2024 13.19B
June 30, 2024 13.34B
March 31, 2024 14.17B
December 31, 2023 14.02B
September 30, 2023 16.42B
June 30, 2023 16.67B
March 31, 2023 16.84B
December 31, 2022 16.78B
September 30, 2022 16.61B
June 30, 2022 16.96B
March 31, 2022 17.48B
December 31, 2021 17.88B
September 30, 2021 6.139B
June 30, 2021 6.585B
March 31, 2021 6.56B
December 31, 2020 6.693B
September 30, 2020 6.977B
June 30, 2020 6.861B
Date Value
March 31, 2020 6.797B
December 31, 2019 5.634B
September 30, 2019 5.559B
June 30, 2019 5.649B
March 31, 2019 3.873B
December 31, 2018 3.483B
September 30, 2018 3.488B
June 30, 2018 3.498B
March 31, 2018 3.553B
December 31, 2017 3.512B
September 30, 2017 3.498B
June 30, 2017 3.457B
March 31, 2017 2.787B
December 31, 2016 2.782B
September 30, 2016 2.84B
June 30, 2016 2.377B
March 31, 2016 2.54B
December 31, 2015 4.732B
September 30, 2015 4.767B
June 30, 2015 12.72B
March 31, 2015 7.854B
December 31, 2014 8.116B
September 30, 2014 8.876B
June 30, 2014 8.653B
March 31, 2014 8.645B

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Becton, Dickinson & Co. 16.81B
DexCom, Inc. 1.378B
Boston Scientific Corp. 12.62B
West Pharmaceutical Services, Inc. 295.60M
Abbott Laboratories 32.61B